Antares Pharma

Ewing, United States Founded: 2000 • Age: 26 yrs Acquired By Halozyme
Existing drugs are reformulated using proprietary pen injectors.
Request Access

About Antares Pharma

Antares Pharma is a company based in Ewing (United States) founded in 2000 was acquired by Halozyme in April 2022.. Antares Pharma offers products and services including ENHANZE, Auto-Injector, and Multi-Dose Pen.

  • Headquarter Ewing, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Antares Pharma, Inc.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $183.98 M
    23
    as on Dec 31, 2021
  • Net Profit
    $46.29 M
    -18
    as on Dec 31, 2021
  • EBITDA
    $65.93 M
    384
    as on Dec 31, 2021
  • Latest Funding Round
    $2.75 M (USD), Post-IPO

    Mar 06, 2018

  • Investors
    Halozyme

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Halozyme

    (Apr 13, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Antares Pharma

Antares Pharma offers a comprehensive portfolio of products and services, including ENHANZE, Auto-Injector, and Multi-Dose Pen. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Enhances drug administration for improved treatment efficacy.

Facilitates self-injection of medications for patient convenience.

Enables multiple doses in a single device for easier management.

People of Antares Pharma
Headcount 50-200
Employee Profiles 35
Board Members and Advisors 5
Employee Profiles
People
Peter Sadowski
SVP, Technology Portfolio & Intellectual Property
People
Michelle Sims
Clinical Specialist
People
Peter J. Graham
EVP, General Counsel, Human Resources, Chief Compliance Officer & Corporate Secretary
People
Robert F. Apple
President & CEO

Unlock access to complete

Board Members and Advisors
people
Anton Gueth
Director

Unlock access to complete

Funding Insights of Antares Pharma

  • Total Funding
  • Total Rounds 4
  • Last Round Post-IPO — $2.8M
  • First Round

    (19 Mar 2007)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2018 Amount Post-IPO - Antares Pharma Valuation

investors

Jun, 2017 Amount Debt – Venture - Antares Pharma Valuation

investors

Jul, 2007 Amount Debt – Venture - Antares Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Antares Pharma

Antares Pharma has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Halozyme, Hercules Capital and Ferring Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture debt financing is provided to companies in multiple sectors.
Founded Year Domain Location
Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics
Founded Year Domain Location
Drug delivery technologies for disease treatment are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Antares Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Antares Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Antares Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Antares Pharma

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Antares Pharma

Frequently Asked Questions about Antares Pharma

When was Antares Pharma founded?

Antares Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.

Where is Antares Pharma located?

Antares Pharma is headquartered in Ewing, United States. It is registered at Ewing, New Jersey, United States.

What is the annual revenue of Antares Pharma?

Annual revenue of Antares Pharma is $183.98M as on Dec 31, 2021.

What does Antares Pharma do?

Antares Pharma was established in 2000 in Ewing, United States, within the pharmaceuticals sector focused on drug delivery systems. Existing medications are reformulated through the VIBEX platform, featuring pre-filled pen injectors for intradermal, subcutaneous, or intramuscular administration. Collaborations are formed with pharmaceutical partners to adapt their products. The development pipeline encompasses injectors for human growth hormone from Ferring, estradiol from Meda, Gelnique from Actavis, and methotrexate.

What products or services does Antares Pharma offer?

Antares Pharma offers ENHANZE, Auto-Injector, and Multi-Dose Pen.

Who are Antares Pharma's investors?

Antares Pharma has 3 investors. Key investors include Halozyme, Hercules Capital, and Ferring Pharmaceuticals.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available